Abiopharma

ARIDIS PHARMACEUTICALS INC. (ARDS)

Symbol	ARDS
Name	ARIDIS PHARMACEUTICALS INC.
Sector	UNDEFINED
Region	North America
Industry	-
Address	95032 United States CA 983 University Avenue Bldg. B
Telephone	(408)385-1742
Fax	—
Email	—
Website	http://www.aridispharma.com/
Incorporation	US
Incorporated On	2014
Employees	—
Fiscal Year	12/31
Public Since	—
Exchanges	OTC
Auditor	Grassi & Co., CPAs, P.C.;
Audit Status	AUDITED
Reporting Status	U.S. Reporting: SEC Reporting
CIK	0001614067
Description	Aridis Pharmaceuticals is a biopharmaceutical company focused on the development of novel, differentiated therapies for infectious diseases. Complementing the clinical stage product pipeline is a disruptive platform technology to discover rare, potent human monoclonal antibodies from patients. Our scientists and leadership team have a proven track record of innovation and successful drug development of therapeutic candidates from early discovery to commercial implementation. Additional info from OTC: Aridis Pharmaceuticals is a biopharmaceutical company focused on the development of novel, differentiated therapies for infectious diseases. Complementing the clinical stage product pipeline is a disruptive platform technology to discover rare, potent human monoclonal antibodies from patients. Our scientists and leadership team have a proven track record of innovation and successful drug development of therapeutic candidates from early discovery to commercial implementation.

2026-02-17 23:52

New Form SCHEDULE 13G/A - Aridis Pharmaceuticals, Inc. Filed: 2026-02-17 AccNo: 0001172661-26-001257 Size: 10 KB

2025-05-15 19:23

New Form SCHEDULE 13G/A - Aridis Pharmaceuticals, Inc. Filed: 2025-05-15 AccNo: 0001172661-25-002241 Size: 10 KB

2025-02-14 21:49

New Form SCHEDULE 13G/A - Aridis Pharmaceuticals, Inc. Filed: 2025-02-14 AccNo: 0001172661-25-001220 Size: 10 KB

2024-12-20 13:00

Aridis Provides Corporate Update

2024-11-14 21:47

New Form SC 13G/A - Aridis Pharmaceuticals, Inc. Filed: 2024-11-14 AccNo: 0001172661-24-005286 Size: 90 KB

2024-08-27 15:35

Expert Market symbol attribute type Security_Name was changed. Previous value: -. New value: ARIDIS PHARMACEUTICAL INC.

2024-08-27 08:16

OTCQX U.S. Premier symbol attribute type Security_Name was changed. Previous value: CONSUMERS BANCORP INC. New value: ARIDIS PHARMACEUTICAL INC.

2024-07-24 11:30

enGene Announces Appointment of Ron Cooper as Chief Executive Officer

2024-06-29 00:36

Director Windham-Bannister Susan Richards 🟢 acquired 200.0K shares (1 derivative) of Aridis Pharmaceuticals, Inc. (ARDS) at $0.06 Transaction Date: Jun 27, 2024 | Filing ID: 025678

2024-06-29 00:36

Director HAMILTON JOHN F 🟢 acquired 200.0K shares (1 derivative) of Aridis Pharmaceuticals, Inc. (ARDS) at $0.06 Transaction Date: Jun 27, 2024 | Filing ID: 025677